SEP-479

· Septerna, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEP-479, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants [Phase 1]